Abstract:Repair of DNA double strand breaks (DSBs) occurs through multiple distinct repair pathways including canonical and microhomology-mediated/Pol Q-dependent end joining (c-NHEJ and alt-NHEJ), homologous recombination (HR), and single strand annealing (SSA). Exactly how a particular DSB dictates which pathway is selected for repair, and the extent to which different DSB repair pathways cross-talk with each other is incompletely understood, but appears to be influenced by the specific type of DNA ends, the extent of DNA resection, the cell state and stage of the cell cycle, and the chromatin context around the break. To simultaneously interrogate multiple DNA DSB repair pathways in a systems-based manner at the single cell level, we built upon the pioneering DSB repair reporter systems created by the Jasin, Stark, Scharenberg and Certo labs to create several new CRISPR-based DNA DSB reporter systems that readout the repair of a single genomic DNA DSB by error-free c-NHEJ, mutagenic c- and alt-NHEJ, HR or SSA using multi-color fluorescence-based imaging and flow cytometry approaches. Using these DSB reporter systems we show that competition between short-range and long-range end resection influences the choice between repair by HR versus SSA, demonstrate accepted and novel functions for a variety of DNA damage sensors and repair proteins in NHEJ and HR, and illustrate the feasibility of using this system to interrogate the effects of patient-specific mutations in DNA repair proteins on DNA DSB repair pathway choice. Finally, we show that DNA DSBs created by topoisomerase inhibitor treatment in live but DNA-damaged tumor cells are capable of activating anti-tumor immune responses by signaling through both canonical and non-canonical DNA break sensing and response pathways. Citation Format: Alex Kruswick, Bert van de Kooij, Tiffany R. Emmons, Ganapathy Sriram, Emma D. Martin, Anjali Arvind, Haico van Attikum, Michael B. Yaffe. Using systems approaches to interrogate DNA double strand break signaling and repair for optimal tumor cell killing [abstract]. In: Proceedings of the AACR Special Conference in Cancer Research: DNA Damage Repair: From Basic Science to Future Clinical Application; 2024 Jan 9-11; Washington, DC. Philadelphia (PA): AACR; Cancer Res 2024;84(1 Suppl) nr IA015.

Evolution-based screening enables genome-wide prioritization and discovery of DNA repair genes

Mapping the Genetic Landscape of DNA Double-strand Break Repair

Tumor Diversity and Evolution Revealed Through RADseq

DNA Mismatch Repair Preferentially Protects Genes from Mutation.

A comprehensive genetic catalog of human double-strand break repair

Kinome-wide Screening Uncovers A Role for Bromodomain Protein 3 in DNA Double-stranded Break Repair

Developmental progression of DNA double-strand break repair deciphered by a single-allele resolution mutation classifier

Revolutionizing DNA repair research and cancer therapy with CRISPR–Cas screens

Evolving Insights: How DNA Repair Pathways Impact Cancer Evolution

DNA damage repair system in C57BL/6 J mice is evolutionarily stable

Quantitative, titratable and high-throughput reporter assays to measure DNA double strand break repair activity in cells

Exploring factors influencing choice of DNA double-strand break repair pathways

The contribution of DNA repair pathways to genome editing and evolution in filamentous pathogens.

A robust CRISPR-Cas9-based fluorescent reporter assay for the detection and quantification of DNA double-strand break repair

Studying DNA Double-Strand Break Repair: An Ever-Growing Toolbox

Global Detection of DNA Repair Outcomes Induced by CRISPR-Cas9

Convergent evolution of epigenome recruited DNA repair across the Tree of Life

A systematic CRISPR screen defines mutational mechanisms underpinning signatures caused by replication errors and endogenous DNA damage

A genetic map of the response to DNA damage in human cells

Abstract IA015: Using systems approaches to interrogate DNA double strand break signaling and repair for optimal tumor cell killing

An Evolutionary Perspective On Single-Nucleotide Polymorphism Screening In Molecular Cancer Epidemiology